Ascendis Pharma

ASND · NASDAQ🇩🇰

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in about 1 month

after market closes

Total Revenue

€251M

Previous year: €63.5M

+294.8%

EPS

-€1.17

Previous year: -€1.89

-38.1%

EPS (Basic & Diluted)

-€1.17

Previous year: -€1.72

Previous year: €47.4M

Previous year: €1.22B

+11.1%

Loading...

Ascendis Pharma

Unlock previous datapoints

Upgrade

Ascendis Pharma

Unlock previous datapoints

Upgrade

Ascendis Pharma Revenue by Segment

Revenue by Segment

SKYTROFA Revenue

CapyFin.com

YORVIPATH Revenue

CapyFin.com

Commercial Products Revenue

CapyFin.com

Services & Clinical Supply Revenue

CapyFin.com

Licenses Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$13.2B

P/E Ratio

-40.40

Sector

N/A

Industry

N/A

52-Week High

$242

52-Week Low

$137

EPS (Basic & Diluted)

-$1.17

Shares Outstanding

61.7M

Products

Get in Touch

Resources

Ascendis Pharma

Ascendis Pharma

Ascendis Pharma

Ascendis Pharma Revenue by Segment

Revenue by Segment

SKYTROFA Revenue

YORVIPATH Revenue

Commercial Products Revenue

Services & Clinical Supply Revenue

Licenses Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics